Around 9% of adults in the United States (65 and older) have reportedly used GLP-1s like Ozempic and Wegovy. As more people have used these medications, it has transformed the conversation around obesity. They’ve helped many people lose a significant amount of weight. Additionally, they have become increasingly common among older adults seeking better health outcomes. However, emerging research suggests that rapid weight loss and changes in body composition associated with GLP-1 medications may have unintended effects on bone health. Aging already increases the risk of osteoporosis, fractures, and loss of muscle mass, so many people are wondering about the impact of GLP-1s on overall bone health. Here’s what older adults should ask their doctors before starting one.
